JNJ

J&J Directors Win Dismissal of Investor ‘Red Flags’ Suit
Bloomberg
Wed, 10/5/11 - 09:56 am
JNJ
investors
recalls
Omnicare
Valeant Pharma Offer Tops Paladin's
Yahoo/Zacks.com
Fri, 09/30/11 - 09:29 am
Valeant Pharmaceuticals
Paladin
Cephalon
JNJ
Dermik
Sanofi
Rivaroxaban Meets Primary Endpoint in ATLAS ACS TIMI 51
Forbes
Fri, 09/30/11 - 09:26 am
rivaroxaban
JNJ
Xarelto
acute coronary syndrome
Bayer
Are HIV Drugmakers Doomed?
Motley Fool
Fri, 09/30/11 - 09:25 am
HIV
Pfizer
Merck
JNJ
Bristol-Myers Squibb
Sangamo BioSciences
Gilead
Abbott Laboratories
Merck sells stake in OTC drug venture to J&J unit
Marketwatch
Wed, 09/28/11 - 06:07 pm
OTC
Merck
JNJ
McNeil
J&J company Ethicon Endo-Surgery buys medical device firm SterilMed for undisclosed terms
Yahoo/AP
Wed, 09/28/11 - 11:32 am
JNJ
Ethicon-Endo Surgery
M&A
SterilMed
J&J's Doxil Woes Show Shortages Aren't Easily Fixed
Motley Fool
Tue, 09/27/11 - 07:26 pm
Doxil
JNJ
drug shortages
cancer
Johnson & Johnson's Xarelto Not a Cure for Pipeline Concerns
Seeking Alpha
Sun, 09/25/11 - 01:05 pm
JNJ
Xarelto
Healthcare: 8 Safe Bets For Dividends And Great Returns
Seeking Alpha
Sat, 09/24/11 - 12:52 pm
Abbot
Merck
Eli Lilly
JNJ
Bristol-Myers Squibb
Novartis
Pfizer
AstraZeneca
J&J Recall Watch: Eprex Anemia Drug Pulled on Potency Worries
WSJ Online
Fri, 09/23/11 - 12:01 pm
Eprex
anemia
recalls
JNJ
Top High-Dividend Healthcare Stocks
Seeking Alpha
Thu, 09/22/11 - 02:20 pm
dividends
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
GSK
JNJ
Eli Lilly
Merck
Novartis
Pfizer
Sanofi
J&J Begins to Rebound from Recalls
Barron's
Wed, 09/21/11 - 11:13 pm
recalls
JNJ
More Data on Vertex's Incivek
Yahoo/Zacks.com
Tue, 09/20/11 - 11:07 am
Vertex
Incivek
hepatitis C
Merck
JNJ
Victrelis
Analysis: New drugs drive prostate cancer market
Yahoo/AP
Mon, 09/19/11 - 06:08 pm
prostate cancer
Dendreon
Exelixis
JNJ
MDV3100
Medivation
Provenge
cabozatinib
Zytiga
Tylenol Supplies Low for Flu Season
WSJ
Sun, 09/18/11 - 12:14 pm
Tylenol
JNJ
recalls
10 Hep C Stocks on Wall Street's Watch List
TheStreet.com
Thu, 09/15/11 - 11:58 am
hepatitis C
Vertex
Merck
Anadyx
Pharmasset
Gilead
Bristol-Myers Squibb
JNJ
Medivir
Achillion
Inhibitex
Indenix
The Importance Of Due Diligence (Exemplified By Johnson & Johnson)
Seeking Alpha
Thu, 09/15/11 - 09:38 am
JNJ
due diligence
J&J Pays $85M Fine Over Natrecor Marketing
Pharmalot
Wed, 09/14/11 - 07:14 pm
Scios
Natrecor
misbranding
JNJ
off-label
Boston Scientific taps J&J exec as its next CEO
Reuters
Wed, 09/14/11 - 11:12 am
JNJ
Boston Scientific
Michael Mahoney
Four Biotech Picks to Fight Hepatitis C
Barron's
Wed, 09/14/11 - 11:07 am
hepatitis C
Achillion
Pharmasset
Inhibitex
Medivir
Vertex
JNJ

Pages